{
  "generated": "2025-10-23T09:24:42.149462+00:00",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "source_evidence": "entries/psychological/glycine-ment-glycine-mood/mental_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "MENT-GLYCINE-MOOD_01",
      "year": 2014,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "negative_symptoms",
      "population": "Adults with negative symptoms concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/ment-glycine-mood-01",
      "url": "https://doi.org/10.1234/ment-glycine-mood-01",
      "citation": "MENT-GLYCINE-MOOD_01 (2014); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with negative symptoms concerns; Outcome: negative_symptoms; DOI: 10.1234/ment-glycine-mood-01; Adverse Events: None reported."
    },
    {
      "study_id": "MENT-GLYCINE-MOOD_02",
      "year": 2015,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "negative_symptoms",
      "population": "Adults with negative symptoms concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/ment-glycine-mood-02",
      "url": "https://doi.org/10.1234/ment-glycine-mood-02",
      "citation": "MENT-GLYCINE-MOOD_02 (2015); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with negative symptoms concerns; Outcome: negative_symptoms; DOI: 10.1234/ment-glycine-mood-02; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "MENT-GLYCINE-MOOD_03",
      "year": 2016,
      "design": "randomized controlled trial",
      "journal": "mental_health_journal",
      "outcome": "negative_symptoms",
      "population": "Adults with negative symptoms concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/ment-glycine-mood-03",
      "url": "https://doi.org/10.1234/ment-glycine-mood-03",
      "citation": "MENT-GLYCINE-MOOD_03 (2016); Journal: mental_health_journal; Design: randomized controlled trial; Population: Adults with negative symptoms concerns; Outcome: negative_symptoms; DOI: 10.1234/ment-glycine-mood-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/ment-glycine-mood-01",
      "study_ids": [
        "MENT-GLYCINE-MOOD_01"
      ],
      "primary_study_id": "MENT-GLYCINE-MOOD_01",
      "url": "https://doi.org/10.1234/ment-glycine-mood-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ment-glycine-mood-02",
      "study_ids": [
        "MENT-GLYCINE-MOOD_02"
      ],
      "primary_study_id": "MENT-GLYCINE-MOOD_02",
      "url": "https://doi.org/10.1234/ment-glycine-mood-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/ment-glycine-mood-03",
      "study_ids": [
        "MENT-GLYCINE-MOOD_03"
      ],
      "primary_study_id": "MENT-GLYCINE-MOOD_03",
      "url": "https://doi.org/10.1234/ment-glycine-mood-03"
    }
  ],
  "manifest_hash": "sha256:84d2c123d0aca9cb248332cb6356c61109788ce8c80d34c4b6a912e2b060c3f7"
}
